nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—ABCB1—colon cancer	0.644	1	CbGaD
Fluphenazine—HTR2A—myenteric nerve plexus—colon cancer	0.0107	0.101	CbGeAlD
Fluphenazine—HTR2A—vein—colon cancer	0.00689	0.0651	CbGeAlD
Fluphenazine—Salivation—Irinotecan—colon cancer	0.0045	0.0414	CcSEcCtD
Fluphenazine—Ileus paralytic—Vincristine—colon cancer	0.00414	0.0381	CcSEcCtD
Fluphenazine—CALM2—endothelium—colon cancer	0.00391	0.0369	CbGeAlD
Fluphenazine—CALM1—endothelium—colon cancer	0.00389	0.0368	CbGeAlD
Fluphenazine—Parkinsonism—Fluorouracil—colon cancer	0.00368	0.0338	CcSEcCtD
Fluphenazine—CALM2—blood vessel—colon cancer	0.00361	0.0341	CbGeAlD
Fluphenazine—CALM1—blood vessel—colon cancer	0.00359	0.0339	CbGeAlD
Fluphenazine—Pigmentation disorder—Capecitabine—colon cancer	0.0035	0.0322	CcSEcCtD
Fluphenazine—CALM2—gall bladder—colon cancer	0.00339	0.0321	CbGeAlD
Fluphenazine—Akathisia—Irinotecan—colon cancer	0.00315	0.029	CcSEcCtD
Fluphenazine—Ileus paralytic—Capecitabine—colon cancer	0.0027	0.0248	CcSEcCtD
Fluphenazine—HTR2A—endothelium—colon cancer	0.00237	0.0224	CbGeAlD
Fluphenazine—HTR2A—blood vessel—colon cancer	0.00219	0.0207	CbGeAlD
Fluphenazine—CALM3—smooth muscle tissue—colon cancer	0.00215	0.0203	CbGeAlD
Fluphenazine—CALM2—embryo—colon cancer	0.00215	0.0203	CbGeAlD
Fluphenazine—CALM1—embryo—colon cancer	0.00214	0.0202	CbGeAlD
Fluphenazine—Tenderness—Fluorouracil—colon cancer	0.00192	0.0176	CcSEcCtD
Fluphenazine—Leukocytosis—Fluorouracil—colon cancer	0.00178	0.0164	CcSEcCtD
Fluphenazine—CALM2—epithelium—colon cancer	0.00176	0.0166	CbGeAlD
Fluphenazine—CALM1—epithelium—colon cancer	0.00175	0.0165	CbGeAlD
Fluphenazine—Appetite absent—Methotrexate—colon cancer	0.00175	0.0161	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Irinotecan—colon cancer	0.00169	0.0156	CcSEcCtD
Fluphenazine—CALM2—smooth muscle tissue—colon cancer	0.00169	0.016	CbGeAlD
Fluphenazine—CALM1—smooth muscle tissue—colon cancer	0.00168	0.0159	CbGeAlD
Fluphenazine—HTR1A—renal system—colon cancer	0.00166	0.0157	CbGeAlD
Fluphenazine—CALM2—renal system—colon cancer	0.00163	0.0154	CbGeAlD
Fluphenazine—CALM1—renal system—colon cancer	0.00162	0.0153	CbGeAlD
Fluphenazine—Urine output increased—Vincristine—colon cancer	0.00162	0.0149	CcSEcCtD
Fluphenazine—CALM3—bone marrow—colon cancer	0.00157	0.0148	CbGeAlD
Fluphenazine—CALM3—vagina—colon cancer	0.0015	0.0142	CbGeAlD
Fluphenazine—Polyuria—Vincristine—colon cancer	0.00148	0.0136	CcSEcCtD
Fluphenazine—ABCB1—blood vessel—colon cancer	0.00143	0.0135	CbGeAlD
Fluphenazine—Photosensitivity—Fluorouracil—colon cancer	0.00138	0.0127	CcSEcCtD
Fluphenazine—Renal failure acute—Irinotecan—colon cancer	0.00137	0.0126	CcSEcCtD
Fluphenazine—CALM2—lymphoid tissue—colon cancer	0.00135	0.0128	CbGeAlD
Fluphenazine—CALM1—lymphoid tissue—colon cancer	0.00135	0.0127	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Irinotecan—colon cancer	0.00134	0.0123	CcSEcCtD
Fluphenazine—CALM2—digestive system—colon cancer	0.00134	0.0126	CbGeAlD
Fluphenazine—CALM1—digestive system—colon cancer	0.00133	0.0126	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Irinotecan—colon cancer	0.00131	0.012	CcSEcCtD
Fluphenazine—HTR2A—embryo—colon cancer	0.0013	0.0123	CbGeAlD
Fluphenazine—HRH1—epithelium—colon cancer	0.00127	0.012	CbGeAlD
Fluphenazine—CALM3—liver—colon cancer	0.00127	0.012	CbGeAlD
Fluphenazine—CYP1A2—renal system—colon cancer	0.00126	0.0119	CbGeAlD
Fluphenazine—Lethargy—Fluorouracil—colon cancer	0.00124	0.0114	CcSEcCtD
Fluphenazine—Cardiac arrest—Vincristine—colon cancer	0.00124	0.0114	CcSEcCtD
Fluphenazine—CALM2—bone marrow—colon cancer	0.00123	0.0116	CbGeAlD
Fluphenazine—HRH1—smooth muscle tissue—colon cancer	0.00123	0.0116	CbGeAlD
Fluphenazine—CALM1—bone marrow—colon cancer	0.00123	0.0116	CbGeAlD
Fluphenazine—Cardiac arrest—Irinotecan—colon cancer	0.0012	0.0111	CcSEcCtD
Fluphenazine—CALM2—vagina—colon cancer	0.00118	0.0111	CbGeAlD
Fluphenazine—CALM1—vagina—colon cancer	0.00117	0.0111	CbGeAlD
Fluphenazine—Cardiac arrest—Fluorouracil—colon cancer	0.00115	0.0106	CcSEcCtD
Fluphenazine—CYP2E1—renal system—colon cancer	0.00114	0.0107	CbGeAlD
Fluphenazine—Pancytopenia—Vincristine—colon cancer	0.00107	0.00982	CcSEcCtD
Fluphenazine—HTR2A—epithelium—colon cancer	0.00106	0.0101	CbGeAlD
Fluphenazine—Urine output increased—Capecitabine—colon cancer	0.00106	0.00971	CcSEcCtD
Fluphenazine—Dysphagia—Fluorouracil—colon cancer	0.00105	0.00965	CcSEcCtD
Fluphenazine—Eosinophilia—Fluorouracil—colon cancer	0.00104	0.00955	CcSEcCtD
Fluphenazine—CYP1A2—digestive system—colon cancer	0.00104	0.00978	CbGeAlD
Fluphenazine—Photosensitivity reaction—Vincristine—colon cancer	0.00103	0.00944	CcSEcCtD
Fluphenazine—HTR2A—smooth muscle tissue—colon cancer	0.00103	0.00969	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Irinotecan—colon cancer	0.00102	0.00936	CcSEcCtD
Fluphenazine—Pneumonia—Vincristine—colon cancer	0.00101	0.00927	CcSEcCtD
Fluphenazine—Pancytopenia—Fluorouracil—colon cancer	0.000996	0.00916	CcSEcCtD
Fluphenazine—CALM2—liver—colon cancer	0.000995	0.0094	CbGeAlD
Fluphenazine—CALM1—liver—colon cancer	0.00099	0.00936	CbGeAlD
Fluphenazine—HTR2A—renal system—colon cancer	0.000987	0.00933	CbGeAlD
Fluphenazine—Pneumonia—Irinotecan—colon cancer	0.000982	0.00903	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000974	0.00896	CcSEcCtD
Fluphenazine—CALM3—lymph node—colon cancer	0.000971	0.00918	CbGeAlD
Fluphenazine—HRH1—digestive system—colon cancer	0.00097	0.00916	CbGeAlD
Fluphenazine—Polyuria—Capecitabine—colon cancer	0.000965	0.00888	CcSEcCtD
Fluphenazine—Photosensitivity—Capecitabine—colon cancer	0.000965	0.00888	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Fluorouracil—colon cancer	0.000957	0.0088	CcSEcCtD
Fluphenazine—CYP2E1—lymphoid tissue—colon cancer	0.000943	0.00891	CbGeAlD
Fluphenazine—Pneumonia—Fluorouracil—colon cancer	0.00094	0.00865	CcSEcCtD
Fluphenazine—CYP2E1—digestive system—colon cancer	0.000932	0.0088	CbGeAlD
Fluphenazine—Renal failure acute—Capecitabine—colon cancer	0.000918	0.00845	CcSEcCtD
Fluphenazine—CYP2D6—renal system—colon cancer	0.0009	0.0085	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Capecitabine—colon cancer	0.000898	0.00827	CcSEcCtD
Fluphenazine—Agranulocytosis—Fluorouracil—colon cancer	0.000872	0.00803	CcSEcCtD
Fluphenazine—Lethargy—Capecitabine—colon cancer	0.000865	0.00796	CcSEcCtD
Fluphenazine—HRH1—vagina—colon cancer	0.000856	0.00809	CbGeAlD
Fluphenazine—ABCB1—embryo—colon cancer	0.000855	0.00808	CbGeAlD
Fluphenazine—ADRA2A—vagina—colon cancer	0.000841	0.00795	CbGeAlD
Fluphenazine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000841	0.00774	CcSEcCtD
Fluphenazine—HTR2A—digestive system—colon cancer	0.00081	0.00765	CbGeAlD
Fluphenazine—Cardiac arrest—Capecitabine—colon cancer	0.000806	0.00742	CcSEcCtD
Fluphenazine—Urine output increased—Methotrexate—colon cancer	0.000786	0.00723	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—colon cancer	0.000778	0.00716	CcSEcCtD
Fluphenazine—CYP1A2—liver—colon cancer	0.000772	0.00729	CbGeAlD
Fluphenazine—CALM2—lymph node—colon cancer	0.000763	0.00721	CbGeAlD
Fluphenazine—CALM1—lymph node—colon cancer	0.000759	0.00717	CbGeAlD
Fluphenazine—CYP2D6—digestive system—colon cancer	0.000738	0.00697	CbGeAlD
Fluphenazine—Muscle spasms—Irinotecan—colon cancer	0.000733	0.00675	CcSEcCtD
Fluphenazine—Dysphagia—Capecitabine—colon cancer	0.000733	0.00674	CcSEcCtD
Fluphenazine—Asthma—Capecitabine—colon cancer	0.000733	0.00674	CcSEcCtD
Fluphenazine—Erythema—Fluorouracil—colon cancer	0.00073	0.00672	CcSEcCtD
Fluphenazine—Agitation—Vincristine—colon cancer	0.00072	0.00662	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—colon cancer	0.000719	0.00661	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—colon cancer	0.000719	0.00661	CcSEcCtD
Fluphenazine—HTR2A—vagina—colon cancer	0.000715	0.00676	CbGeAlD
Fluphenazine—Leukopenia—Vincristine—colon cancer	0.000701	0.00645	CcSEcCtD
Fluphenazine—ABCB1—epithelium—colon cancer	0.000698	0.00659	CbGeAlD
Fluphenazine—Pancytopenia—Capecitabine—colon cancer	0.000696	0.0064	CcSEcCtD
Fluphenazine—CYP2E1—liver—colon cancer	0.000694	0.00656	CbGeAlD
Fluphenazine—Vision blurred—Fluorouracil—colon cancer	0.000688	0.00633	CcSEcCtD
Fluphenazine—Renal failure acute—Methotrexate—colon cancer	0.000683	0.00629	CcSEcCtD
Fluphenazine—Leukopenia—Irinotecan—colon cancer	0.000683	0.00628	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Capecitabine—colon cancer	0.000681	0.00626	CcSEcCtD
Fluphenazine—Hypertension—Vincristine—colon cancer	0.000676	0.00622	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—colon cancer	0.000669	0.00615	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Capecitabine—colon cancer	0.000669	0.00615	CcSEcCtD
Fluphenazine—Hypertension—Irinotecan—colon cancer	0.000658	0.00606	CcSEcCtD
Fluphenazine—Pneumonia—Capecitabine—colon cancer	0.000657	0.00604	CcSEcCtD
Fluphenazine—Leukopenia—Fluorouracil—colon cancer	0.000654	0.00602	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—colon cancer	0.000652	0.006	CcSEcCtD
Fluphenazine—ABCB1—renal system—colon cancer	0.000647	0.00611	CbGeAlD
Fluphenazine—Lethargy—Methotrexate—colon cancer	0.000644	0.00592	CcSEcCtD
Fluphenazine—Anaphylactic shock—Vincristine—colon cancer	0.000639	0.00588	CcSEcCtD
Fluphenazine—Anaphylactic shock—Irinotecan—colon cancer	0.000622	0.00573	CcSEcCtD
Fluphenazine—Agranulocytosis—Capecitabine—colon cancer	0.00061	0.00561	CcSEcCtD
Fluphenazine—HTR2A—liver—colon cancer	0.000603	0.0057	CbGeAlD
Fluphenazine—Hypotension—Vincristine—colon cancer	0.000597	0.0055	CcSEcCtD
Fluphenazine—Anaphylactic shock—Fluorouracil—colon cancer	0.000596	0.00549	CcSEcCtD
Fluphenazine—Flupentixol—ABCB1—colon cancer	0.000587	0.282	CrCbGaD
Fluphenazine—Tachycardia—Fluorouracil—colon cancer	0.000582	0.00535	CcSEcCtD
Fluphenazine—Hypotension—Irinotecan—colon cancer	0.000582	0.00535	CcSEcCtD
Fluphenazine—Oedema peripheral—Capecitabine—colon cancer	0.000578	0.00531	CcSEcCtD
Fluphenazine—Hypotension—Fluorouracil—colon cancer	0.000557	0.00513	CcSEcCtD
Fluphenazine—Decreased appetite—Vincristine—colon cancer	0.000556	0.00511	CcSEcCtD
Fluphenazine—Dyspnoea—Irinotecan—colon cancer	0.000555	0.00511	CcSEcCtD
Fluphenazine—HRH1—lymph node—colon cancer	0.000554	0.00523	CbGeAlD
Fluphenazine—Somnolence—Irinotecan—colon cancer	0.000553	0.00509	CcSEcCtD
Fluphenazine—CYP2D6—liver—colon cancer	0.00055	0.00519	CbGeAlD
Fluphenazine—Constipation—Vincristine—colon cancer	0.000547	0.00503	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—colon cancer	0.000545	0.00502	CcSEcCtD
Fluphenazine—ADRA2A—lymph node—colon cancer	0.000544	0.00514	CbGeAlD
Fluphenazine—Decreased appetite—Irinotecan—colon cancer	0.000541	0.00498	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—colon cancer	0.00054	0.00497	CcSEcCtD
Fluphenazine—ABCB1—lymphoid tissue—colon cancer	0.000537	0.00508	CbGeAlD
Fluphenazine—Constipation—Irinotecan—colon cancer	0.000532	0.0049	CcSEcCtD
Fluphenazine—Dyspnoea—Fluorouracil—colon cancer	0.000531	0.00489	CcSEcCtD
Fluphenazine—ABCB1—digestive system—colon cancer	0.000531	0.00501	CbGeAlD
Fluphenazine—Somnolence—Fluorouracil—colon cancer	0.00053	0.00488	CcSEcCtD
Fluphenazine—Decreased appetite—Fluorouracil—colon cancer	0.000518	0.00477	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—colon cancer	0.000518	0.00477	CcSEcCtD
Fluphenazine—Erythema—Capecitabine—colon cancer	0.00051	0.0047	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—colon cancer	0.000507	0.00466	CcSEcCtD
Fluphenazine—Body temperature increased—Vincristine—colon cancer	0.000505	0.00465	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—colon cancer	0.000498	0.00458	CcSEcCtD
Fluphenazine—Body temperature increased—Irinotecan—colon cancer	0.000492	0.00453	CcSEcCtD
Fluphenazine—Muscle spasms—Capecitabine—colon cancer	0.000491	0.00452	CcSEcCtD
Fluphenazine—ABCB1—bone marrow—colon cancer	0.000489	0.00462	CbGeAlD
Fluphenazine—Pneumonia—Methotrexate—colon cancer	0.000489	0.0045	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—colon cancer	0.000486	0.00447	CcSEcCtD
Fluphenazine—Vision blurred—Capecitabine—colon cancer	0.000481	0.00443	CcSEcCtD
Fluphenazine—Urticaria—Fluorouracil—colon cancer	0.000474	0.00436	CcSEcCtD
Fluphenazine—Body temperature increased—Fluorouracil—colon cancer	0.000471	0.00434	CcSEcCtD
Fluphenazine—Hypersensitivity—Vincristine—colon cancer	0.000471	0.00433	CcSEcCtD
Fluphenazine—ABCB1—vagina—colon cancer	0.000469	0.00443	CbGeAlD
Fluphenazine—Hypersensitivity—Irinotecan—colon cancer	0.000459	0.00422	CcSEcCtD
Fluphenazine—Leukopenia—Capecitabine—colon cancer	0.000457	0.0042	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—colon cancer	0.000454	0.00418	CcSEcCtD
Fluphenazine—Hypertension—Capecitabine—colon cancer	0.000441	0.00405	CcSEcCtD
Fluphenazine—Hypersensitivity—Fluorouracil—colon cancer	0.000439	0.00404	CcSEcCtD
Fluphenazine—Dry mouth—Capecitabine—colon cancer	0.000425	0.00391	CcSEcCtD
Fluphenazine—Pruritus—Fluorouracil—colon cancer	0.000422	0.00388	CcSEcCtD
Fluphenazine—Tachycardia—Capecitabine—colon cancer	0.000407	0.00374	CcSEcCtD
Fluphenazine—Skin disorder—Capecitabine—colon cancer	0.000405	0.00372	CcSEcCtD
Fluphenazine—Headache—Vincristine—colon cancer	0.0004	0.00368	CcSEcCtD
Fluphenazine—ABCB1—liver—colon cancer	0.000395	0.00373	CbGeAlD
Fluphenazine—Headache—Irinotecan—colon cancer	0.00039	0.00359	CcSEcCtD
Fluphenazine—Hypotension—Capecitabine—colon cancer	0.000389	0.00358	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—colon cancer	0.00038	0.0035	CcSEcCtD
Fluphenazine—Nausea—Vincristine—colon cancer	0.00038	0.00349	CcSEcCtD
Fluphenazine—Headache—Fluorouracil—colon cancer	0.000373	0.00344	CcSEcCtD
Fluphenazine—Dyspnoea—Capecitabine—colon cancer	0.000371	0.00342	CcSEcCtD
Fluphenazine—Nausea—Irinotecan—colon cancer	0.00037	0.0034	CcSEcCtD
Fluphenazine—Decreased appetite—Capecitabine—colon cancer	0.000362	0.00333	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—colon cancer	0.000358	0.0033	CcSEcCtD
Fluphenazine—Constipation—Capecitabine—colon cancer	0.000356	0.00328	CcSEcCtD
Fluphenazine—Nausea—Fluorouracil—colon cancer	0.000354	0.00326	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—colon cancer	0.00034	0.00313	CcSEcCtD
Fluphenazine—Urticaria—Capecitabine—colon cancer	0.000331	0.00305	CcSEcCtD
Fluphenazine—Body temperature increased—Capecitabine—colon cancer	0.000329	0.00303	CcSEcCtD
Fluphenazine—Nefazodone—ABCB1—colon cancer	0.000328	0.158	CrCbGaD
Fluphenazine—Triflupromazine—ABCB1—colon cancer	0.00032	0.154	CrCbGaD
Fluphenazine—Anaphylactic shock—Methotrexate—colon cancer	0.00031	0.00285	CcSEcCtD
Fluphenazine—Hypersensitivity—Capecitabine—colon cancer	0.000307	0.00282	CcSEcCtD
Fluphenazine—Trazodone—ABCB1—colon cancer	0.000303	0.146	CrCbGaD
Fluphenazine—ABCB1—lymph node—colon cancer	0.000303	0.00286	CbGeAlD
Fluphenazine—Skin disorder—Methotrexate—colon cancer	0.000301	0.00277	CcSEcCtD
Fluphenazine—Pruritus—Capecitabine—colon cancer	0.000295	0.00271	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—colon cancer	0.00029	0.00267	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—colon cancer	0.000276	0.00254	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—colon cancer	0.000276	0.00254	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—colon cancer	0.00027	0.00248	CcSEcCtD
Fluphenazine—Headache—Capecitabine—colon cancer	0.000261	0.0024	CcSEcCtD
Fluphenazine—Nausea—Capecitabine—colon cancer	0.000247	0.00228	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—colon cancer	0.000246	0.00227	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—colon cancer	0.000245	0.00226	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—colon cancer	0.000228	0.0021	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—colon cancer	0.000219	0.00202	CcSEcCtD
Fluphenazine—Trifluoperazine—ABCB1—colon cancer	0.000196	0.0945	CrCbGaD
Fluphenazine—Headache—Methotrexate—colon cancer	0.000194	0.00179	CcSEcCtD
Fluphenazine—Quetiapine—ABCB1—colon cancer	0.000191	0.0916	CrCbGaD
Fluphenazine—Nausea—Methotrexate—colon cancer	0.000184	0.00169	CcSEcCtD
Fluphenazine—Chlorpromazine—ABCB1—colon cancer	0.000154	0.0741	CrCbGaD
Fluphenazine—CALM1—Metabolism—PTGS2—colon cancer	1.45e-05	0.000104	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—colon cancer	1.45e-05	0.000104	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TGFB1—colon cancer	1.45e-05	0.000104	CbGpPWpGaD
Fluphenazine—CALM3—Disease—SRC—colon cancer	1.45e-05	0.000104	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EP300—colon cancer	1.45e-05	0.000104	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PPARG—colon cancer	1.45e-05	0.000103	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—EGFR—colon cancer	1.44e-05	0.000103	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EP300—colon cancer	1.44e-05	0.000103	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EP300—colon cancer	1.44e-05	0.000103	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—AKT1—colon cancer	1.44e-05	0.000103	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—PIK3CA—colon cancer	1.43e-05	0.000103	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CASP3—colon cancer	1.43e-05	0.000102	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—EGFR—colon cancer	1.42e-05	0.000102	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—KRAS—colon cancer	1.42e-05	0.000102	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—AKT1—colon cancer	1.42e-05	0.000101	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—SRC—colon cancer	1.42e-05	0.000101	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—AKT1—colon cancer	1.41e-05	0.000101	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—SRC—colon cancer	1.41e-05	0.000101	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—colon cancer	1.41e-05	0.000101	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CASP3—colon cancer	1.4e-05	0.0001	CbGpPWpGaD
Fluphenazine—CALM2—Disease—SRC—colon cancer	1.4e-05	0.0001	CbGpPWpGaD
Fluphenazine—CALM1—Disease—SRC—colon cancer	1.4e-05	0.0001	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CASP3—colon cancer	1.4e-05	0.0001	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NRAS—colon cancer	1.39e-05	9.98e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCND1—colon cancer	1.39e-05	9.93e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—colon cancer	1.38e-05	9.86e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—KRAS—colon cancer	1.38e-05	9.85e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—KRAS—colon cancer	1.38e-05	9.85e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—EGFR—colon cancer	1.38e-05	9.85e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CTNNB1—colon cancer	1.37e-05	9.84e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—colon cancer	1.37e-05	9.81e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—EP300—colon cancer	1.37e-05	9.79e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCND1—colon cancer	1.37e-05	9.77e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCND1—colon cancer	1.36e-05	9.75e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KRAS—colon cancer	1.36e-05	9.75e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARG—colon cancer	1.36e-05	9.75e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NRAS—colon cancer	1.36e-05	9.74e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NRAS—colon cancer	1.35e-05	9.69e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CTNNB1—colon cancer	1.35e-05	9.68e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CTNNB1—colon cancer	1.35e-05	9.66e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NRAS—colon cancer	1.35e-05	9.65e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NRAS—colon cancer	1.35e-05	9.65e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—HRAS—colon cancer	1.35e-05	9.63e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KRAS—colon cancer	1.34e-05	9.62e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CDKN1A—colon cancer	1.34e-05	9.61e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—EGFR—colon cancer	1.33e-05	9.52e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—EGFR—colon cancer	1.33e-05	9.52e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—HRAS—colon cancer	1.33e-05	9.48e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CDKN1A—colon cancer	1.32e-05	9.46e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CDKN1A—colon cancer	1.32e-05	9.44e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—colon cancer	1.31e-05	9.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PIK3CA—colon cancer	1.31e-05	9.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—colon cancer	1.3e-05	9.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—colon cancer	1.3e-05	9.29e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—colon cancer	1.3e-05	9.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—colon cancer	1.29e-05	9.22e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—colon cancer	1.29e-05	9.2e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—colon cancer	1.28e-05	9.18e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EP300—colon cancer	1.28e-05	9.14e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—colon cancer	1.28e-05	9.14e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EGFR—colon cancer	1.27e-05	9.09e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—colon cancer	1.27e-05	9.08e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—colon cancer	1.26e-05	9.05e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—colon cancer	1.26e-05	9.05e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—colon cancer	1.26e-05	9.05e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—colon cancer	1.26e-05	9.03e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—colon cancer	1.26e-05	9.01e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—colon cancer	1.26e-05	9e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—colon cancer	1.26e-05	9e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EP300—colon cancer	1.26e-05	9e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—colon cancer	1.26e-05	8.99e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—colon cancer	1.26e-05	8.99e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—EP300—colon cancer	1.26e-05	8.99e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EP300—colon cancer	1.25e-05	8.98e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.25e-05	8.98e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—colon cancer	1.25e-05	8.97e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—colon cancer	1.25e-05	8.97e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—colon cancer	1.25e-05	8.96e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—EP300—colon cancer	1.25e-05	8.93e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—colon cancer	1.24e-05	8.89e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SRC—colon cancer	1.24e-05	8.89e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—colon cancer	1.24e-05	8.88e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—colon cancer	1.24e-05	8.84e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—colon cancer	1.23e-05	8.83e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—colon cancer	1.23e-05	8.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—colon cancer	1.23e-05	8.79e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—colon cancer	1.23e-05	8.79e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SRC—colon cancer	1.22e-05	8.75e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SRC—colon cancer	1.22e-05	8.73e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—colon cancer	1.21e-05	8.67e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—colon cancer	1.21e-05	8.66e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—colon cancer	1.21e-05	8.65e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—EP300—colon cancer	1.21e-05	8.64e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—EP300—colon cancer	1.21e-05	8.64e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1A—colon cancer	1.2e-05	8.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—colon cancer	1.2e-05	8.59e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—colon cancer	1.2e-05	8.55e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—colon cancer	1.19e-05	8.55e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—colon cancer	1.19e-05	8.55e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—colon cancer	1.19e-05	8.52e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—colon cancer	1.19e-05	8.5e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—colon cancer	1.19e-05	8.5e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—colon cancer	1.18e-05	8.42e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—colon cancer	1.17e-05	8.4e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—colon cancer	1.17e-05	8.39e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—colon cancer	1.17e-05	8.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—colon cancer	1.17e-05	8.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—colon cancer	1.17e-05	8.37e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—colon cancer	1.17e-05	8.34e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—colon cancer	1.16e-05	8.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—colon cancer	1.16e-05	8.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—colon cancer	1.16e-05	8.31e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—colon cancer	1.16e-05	8.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—colon cancer	1.15e-05	8.27e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—colon cancer	1.15e-05	8.27e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARG—colon cancer	1.15e-05	8.26e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EP300—colon cancer	1.14e-05	8.19e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—colon cancer	1.14e-05	8.18e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—colon cancer	1.14e-05	8.14e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—colon cancer	1.13e-05	8.11e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—colon cancer	1.13e-05	8.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—colon cancer	1.13e-05	8.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—colon cancer	1.12e-05	8.04e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—colon cancer	1.11e-05	7.97e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SRC—colon cancer	1.11e-05	7.96e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—colon cancer	1.11e-05	7.95e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—colon cancer	1.1e-05	7.91e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—colon cancer	1.1e-05	7.89e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1A—colon cancer	1.1e-05	7.85e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—colon cancer	1.1e-05	7.85e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—colon cancer	1.1e-05	7.85e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—colon cancer	1.1e-05	7.84e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—colon cancer	1.09e-05	7.82e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—colon cancer	1.09e-05	7.82e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—colon cancer	1.09e-05	7.8e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—colon cancer	1.09e-05	7.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—colon cancer	1.09e-05	7.77e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—colon cancer	1.09e-05	7.77e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—colon cancer	1.08e-05	7.75e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—colon cancer	1.08e-05	7.7e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—colon cancer	1.07e-05	7.67e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—colon cancer	1.07e-05	7.67e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—colon cancer	1.07e-05	7.66e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—colon cancer	1.07e-05	7.66e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—colon cancer	1.07e-05	7.65e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—colon cancer	1.07e-05	7.65e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—colon cancer	1.07e-05	7.65e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—colon cancer	1.07e-05	7.64e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—colon cancer	1.07e-05	7.63e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—colon cancer	1.07e-05	7.63e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1A—colon cancer	1.06e-05	7.59e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1A—colon cancer	1.06e-05	7.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EP300—colon cancer	1.04e-05	7.47e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—colon cancer	1.04e-05	7.45e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—colon cancer	1.04e-05	7.41e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—colon cancer	1.03e-05	7.39e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—colon cancer	1.03e-05	7.39e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—colon cancer	1.03e-05	7.36e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—colon cancer	1.02e-05	7.32e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—colon cancer	1.02e-05	7.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SRC—colon cancer	1.01e-05	7.26e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—colon cancer	1.01e-05	7.24e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—colon cancer	1.01e-05	7.24e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—colon cancer	1.01e-05	7.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EP300—colon cancer	1.01e-05	7.23e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EP300—colon cancer	1.01e-05	7.23e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—colon cancer	1.01e-05	7.22e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—colon cancer	9.97e-06	7.13e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—colon cancer	9.96e-06	7.13e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—colon cancer	9.94e-06	7.12e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—colon cancer	9.91e-06	7.09e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—colon cancer	9.88e-06	7.07e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—colon cancer	9.87e-06	7.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—colon cancer	9.87e-06	7.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SRC—colon cancer	9.82e-06	7.03e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SRC—colon cancer	9.82e-06	7.03e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—colon cancer	9.76e-06	6.99e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—colon cancer	9.75e-06	6.98e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—colon cancer	9.75e-06	6.98e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—colon cancer	9.56e-06	6.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—colon cancer	9.56e-06	6.84e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—EP300—colon cancer	9.46e-06	6.77e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—colon cancer	9.45e-06	6.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—colon cancer	9.44e-06	6.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—colon cancer	9.44e-06	6.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—colon cancer	9.44e-06	6.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—colon cancer	9.44e-06	6.75e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—colon cancer	9.3e-06	6.66e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—colon cancer	9.29e-06	6.65e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—colon cancer	9.28e-06	6.64e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—colon cancer	9.23e-06	6.61e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—colon cancer	9.21e-06	6.59e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—colon cancer	9.14e-06	6.54e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—colon cancer	9.09e-06	6.51e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—colon cancer	9.08e-06	6.5e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—colon cancer	9.07e-06	6.49e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—colon cancer	9.01e-06	6.45e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—colon cancer	9e-06	6.44e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—colon cancer	8.98e-06	6.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—colon cancer	8.93e-06	6.39e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—colon cancer	8.93e-06	6.39e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—EP300—colon cancer	8.91e-06	6.38e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—colon cancer	8.89e-06	6.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—colon cancer	8.8e-06	6.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—colon cancer	8.8e-06	6.3e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—colon cancer	8.79e-06	6.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—colon cancer	8.78e-06	6.28e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—colon cancer	8.78e-06	6.28e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—colon cancer	8.75e-06	6.26e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—colon cancer	8.74e-06	6.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—colon cancer	8.71e-06	6.23e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—colon cancer	8.71e-06	6.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—colon cancer	8.6e-06	6.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—colon cancer	8.6e-06	6.16e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—colon cancer	8.6e-06	6.16e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—colon cancer	8.59e-06	6.14e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—colon cancer	8.46e-06	6.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—colon cancer	8.4e-06	6.01e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—colon cancer	8.27e-06	5.92e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—colon cancer	8.18e-06	5.86e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—colon cancer	8.13e-06	5.82e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—colon cancer	8.13e-06	5.82e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—colon cancer	7.83e-06	5.6e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—colon cancer	7.72e-06	5.53e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—colon cancer	7.72e-06	5.53e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—colon cancer	7.6e-06	5.44e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—colon cancer	7.59e-06	5.43e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—colon cancer	7.58e-06	5.43e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—EP300—colon cancer	7.55e-06	5.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—colon cancer	7.54e-06	5.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—colon cancer	7.47e-06	5.34e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—colon cancer	7.47e-06	5.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—colon cancer	7.47e-06	5.34e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—colon cancer	7.3e-06	5.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—colon cancer	7.3e-06	5.22e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—colon cancer	7.22e-06	5.17e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—colon cancer	7.22e-06	5.17e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—colon cancer	7.14e-06	5.11e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—colon cancer	7e-06	5.01e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—colon cancer	6.91e-06	4.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—colon cancer	6.91e-06	4.94e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—colon cancer	6.91e-06	4.94e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—colon cancer	6.59e-06	4.72e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—colon cancer	6.31e-06	4.51e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—colon cancer	6.1e-06	4.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—colon cancer	6.1e-06	4.37e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—colon cancer	5.72e-06	4.09e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—colon cancer	5.59e-06	4e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—colon cancer	5.39e-06	3.85e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—colon cancer	4.56e-06	3.27e-05	CbGpPWpGaD
